Presentation Cost-effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation Presenter: S. Lee June 05, 2012 REGISTER for free or LOG IN to view this content Coronary Factoid Up Next Presentation TVT 2012 Case Screening Considerations: Who Should and Shouldn't Have Transfemoral TAVR(2) Presenter: Jean-Michel Paradis June 05, 2012 More slides + Presentation TVT 2012 The Wavecrest: Device Iterations and Clinical Studies Presenter: Brian Whisenant June 05, 2012 Presentation TVT 2012 EU Insights on Withholding TAVR in Futile Patients(2) Presenter: Olaf Wendler June 05, 2012 We Recommend
Presentation TVT 2012 Case Screening Considerations: Who Should and Shouldn't Have Transfemoral TAVR(2) Presenter: Jean-Michel Paradis June 05, 2012
Presentation TVT 2012 The Wavecrest: Device Iterations and Clinical Studies Presenter: Brian Whisenant June 05, 2012
Presentation TVT 2012 EU Insights on Withholding TAVR in Futile Patients(2) Presenter: Olaf Wendler June 05, 2012